Unravelling the human disposition of [14C]-vebreltinib: Faecal recovery of parent drug and a major circulating metabolite defines its mass balance profile.

vebreltinib (APL-101) - Apollomics

http://www.ncbi.nlm.nih.gov/pubmed/42098960

Hang Yin; Hepeng Shi; Jingxuan Wu; Lijun Li; Peilong Zhang; Qiannan Gao; Ruihua Dong; Weizhe Xue

May 8, 2026